Research

CINDRIGO HOLDINGS Ltd: Strategic investor backing and pellet integration strengthen the case

Research

Johan Widmark | 2026-05-13 08:00  Read the report in PDF here Executive Summary  Following its listing on the LSE Main Market in October...

Read More

NANEXA: Strong semaglutide data and reinforced funding extend strategic runway

Analys, Research

Following the license agreement with Moderna in Q4’25, Nanexa continues to advance along three parallel value tracks: the Moderna...

Read More

Crunchfish: Chairman and CEO secure funding while strategic positioning continues to expand

Analys, Research

Not quite in the form we had expected, but with the Chairman and CEO committing to subscribe for the entire issue, Crunchfish has now...

Read More

NANEXA: Funding secured as semaglutide pivot sharpens commercial focus

Analys, Research

Following the breakthrough license deal with Moderna, a global leader in mRNA therapeutics, in Q4’25, Nanexa now pursues two main tracks...

Read More

CRUNCHFISH: System-level positioning in place, commercial traction still pending

Analys, Research

Following last year’s breakthrough integration into India’s payment ecosystem, Crunchfish enters 2026 with a continued focus on...

Read More

NANEXA: First license with Moderna an important validation of PharmaShell

Analys, Research

The announcement of Nanexa’s first licensing deal marks a meaningful validation of the PharmaShell platform, as Moderna, a global leader...

Read More

NANEXA: Intensified focus on deals amid growing funding pressure

Analys, Research

Nanexa’s Q3 report underscores a pivotal moment for the company. While interest in its PharmaShell technology remains strong, with...

Read More

CINDRIGO HOLDINGS: Powering Europe’s clean baseload transition with LSE listing and first revenues

Research

Johan Widmark | 2025-10-30 17:00  Read the report in PDF here Executive Summary  With the admission to the London Stock Exchange Main...

Read More

PROLIGHT: Financing and partner interest strengthen case ahead of regulatory study

Analys, Research

Johan Widmark | 2025-08-29 08:00 READ REPORT IN PDF In Q2, Prolight reported initial positive data from its ongoing whole blood study at St...

Read More

CRUNCHFISH: Improved outlook with NPCI adoption and global validation

Analys, Research

Crunchfish’s new go-to-market strategy for offline payments, splitting the solution into terminals for payment networks and wallets for...

Read More

For new research on growth stocks, sign up to our newsletter